Lysine Metabolism Is a Novel Metabolic Tumor Suppressor Pathway in Breast Cancer

Scientists created a new model to better understand how the obese microenvironment alters nuclear receptor function in breast cancer. The obesity related cancer phenotype was PPARγ dependent.